Search the Newsroom
Filter By
Showing 1851 - 1860 of 2709 results
Researchers Use Data Tools to Rapidly Detect Sepsis in Sick Newborns
CHOP researchers used automated tools to identify sepsis in NICU babies hours before clinical recognition of the condition.
PENN/CHOP Team Featured on TheGuardian.com
Prenatal gene editing shows proof-of-concept in treating congenital disease before birth.
CHOP Receives Magnet Designation for Fourth Time
This prestigious designation recognizes organizations that provide the highest-quality care.
Existing Drug May Have Potential to Treat Mitochondrial Disease
New results in cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with mitochondrial disorders.
The Fore Hadley Foundation Donates $55,000 to CDH Research
The Fore Hadley Foundation presented CHOP with a $55,000 grant to support congenital diaphragmatic hernia (CDH) research. The grant will support the research of Drs. Ian Krantz and William Peranteau.
The Tallahassee Democrat Reports on Florida Fetal Surgery Patient
Jayant’s parents, Suni and Emily, temporarily relocated to Philadelphia to ensure their unborn son received the best care possible.
An Update on Elijah Leffingwell — Six Years Later
Fox 6 News reports on patient who underwent fetal surgery midway through his mother’s pregnancy.
Skin Patch Shows Promise for Children with Food Allergies
CHOP participated in an international, multi-site study to determine if a skin patch could help children with peanut allergies.
Sideroblastic Anemia Is a Red-flag Sign of Single Large-scale Mitochondrial DNA Deletion Syndrome
Using the case of a 24-month-old African-American boy, Drs. Ganetzky and Goldstein discuss sideroblastic anemia and how it might be an indicator for multisystem mitochondrial disease.
The Case for Performing Percutaneous Muscle Biopsy
Dr. Cunningham writes about when and why should a muscle biopsy be considered in the evaluation of mitochondrial disease, and how to obtain a muscle biopsy.